Pooled Survival and Response Data From Phase III Randomized Controlled Trials for Gemcitabine-based Regimes in the Treatment of Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

Pooled Survival and Response Data From Phase III Randomized Controlled Trials for Gemcitabine-based Regimes in the Treatment of Advanced Pancreatic Cancer

Published:2013-08 Issue:4 Volume:36 Page:411-414
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Arshad Ali,Al-Leswas Dhya,Al-Taan Omer,Stephenson James,Metcalfe Matthew,Steward William P.,Dennison Ashley R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference21 articles.

1. .Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.;Burris;J Clin Oncol,1997

2. .Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced andor metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dellItalia Meridionale.;Colucci;Cancer,2002

3. .Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.;Berlin;J Clin Oncol,2002

4. .Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer.;Wang;Zhonghua Zhong Liu Za Zhi,2002

5. .A double-blind placebo-controlled, randomized study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.;Bramhall;Br J Cancer,2002

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy;Journal of Materials Chemistry B;2020

2. Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells;Cancer Biology & Therapy;2019-03-13

3. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study;BMC Cancer;2018-12

4. Association Between Opioid Use and Survival Time in Patients With Unresectable Pancreatic Cancer;Pancreas;2018-08

5. Role of Tocotrienols in Chemosensitization of Cancer;Role of Nutraceuticals in Chemoresistance to Cancer;2018